Behavioral contracting to improve adherence in patients with thalassemia.
Twenty-three patients with thalassemia contracted to improve their adherence with subcutaneous desferrioxamine by increasing their number of days of use. Adherence, as measured by empty vial counts, was positively reinforced by careful monitoring and behavioral reward system. Contingency contracting was successful in 76% of patients over a 6-month period, with 69% maintaining improvement in adherence 2 months after the program. Findings supported the efficacy of behavioral intervention strategies in the care of patients with chronic illness.
Koch
D A
DA
New York Hospital-Cornell University Medical College, Department of Pediatrics, NY.
Giardina
P J
PJ
Ryan
M
M
MacQueen
M
M
Hilgartner
M W
MW
D000293:Adolescent; D000328:Adult; D001521:Behavior Therapy / Q000379:methods*; D002648:Child; D002675:Child, Preschool; D003676:Deferoxamine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007260:Infusion Pumps; D008297:Male; D010349:Patient Compliance; D017086:beta-Thalassemia / Q000188:drug therapy* / Q000451:nursing / Q000523:psychology
D003676:Deferoxamine